You are here

  • Home
  • Archive
  • Volume 10, Issue 9
  • Preclinical characterization and clinical translation of pharmacodynamic markers for MK-5890: a human CD27 activating antibody for cancer immunotherapy

Article metrics

Article menu
Clinical/translational cancer immunotherapy
Original research
Preclinical characterization and clinical translation of pharmacodynamic markers for MK-5890: a human CD27 activating antibody for cancer immunotherapy

 

Online download statistics by month:

Online download statistics by month: September 2022 to July 2025

AbstractFullPdf
Sep 2022613619199
Oct 2022410416142
Nov 202220520584
Dec 202211911940
Jan 202310110232
Feb 202311611757
Mar 2023889152
Apr 2023757830
May 2023646739
Jun 2023666926
Jul 2023606235
Aug 2023687026
Sep 2023545430
Oct 2023798337
Nov 2023747525
Dec 202318918928
Jan 2024727655
Feb 2024717428
Mar 2024889169
Apr 2024747444
May 2024666629
Jun 2024565637
Jul 2024747437
Aug 2024535029
Sep 2024707042
Oct 2024959541
Nov 2024757630
Dec 2024666856
Jan 2025747422
Feb 2025444417
Mar 2025898951
Apr 2025899040
May 2025606030
Jun 2025484824
Jul 2025220
Total364736931563